Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Evan Stein

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Stein, Evan

Item TypeName
Concept Hyperlipoproteinemia Type II
Concept Hyperlipoproteinemia Type I
Concept Hyperlipoproteinemia Type III
Academic Article Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial.
Academic Article ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.
Academic Article Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia.
Academic Article Apolipoprotein E-4Philadelphia (Glu13----Lys,Arg145----Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia.
Academic Article What matters most in pediatric familial hypercholesterolemia, genotype or phenotype?
Academic Article HDL abnormalities in familial hypercholesterolemia: Focus on biological functions.
Academic Article Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia.
Academic Article A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia.
Academic Article Nonprogression of coronary artery atherosclerosis in homozygous familial hypercholesterolemia after 31 months of repetitive plasma exchange.
Academic Article Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label).
Academic Article Rosuvastatin reduces non-high-density lipoprotein cholesterol and lipoprotein remnants in patients with dysbetalipoproteinemia (Fredrickson type III hyperlipoproteinemia).
Academic Article Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades.
Academic Article Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia.
Academic Article Effect of Pravastatin in the Treatment of Patients with Type III Hyperlipoproteinemia.
Academic Article Polygenic familial hypercholesterolaemia: does it matter?
Academic Article Repetitive intermittent flow plasma exchange in patients with severe hypercholesterolemia.
Academic Article After ENHANCE: is more LDL cholesterol lowering even better?
Academic Article Trp64----nonsense mutation in the lipoprotein lipase gene.
Academic Article Statins in children. Why and when.
Academic Article A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia.
Academic Article Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations.
Academic Article MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?
Academic Article Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia.
Academic Article Higher triglycerides, lower high-density lipoprotein cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes. A preliminary report.
Academic Article Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
Academic Article Treatment of familial hypercholesterolemia with drugs in children.
Academic Article Effect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia.
Academic Article Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families.
Academic Article Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
Academic Article Lovastatin alone and in combination for treatment of primary hypercholesterolemia.
Academic Article Changes in plasma lipid and lipoprotein fractions after alteration in dietary cholesterol, polyunsaturated, saturated, and total fat in free-living normal and hypercholesterolemic children.
Academic Article PCSK9: the Critical Role of Familial Hypercholesterolemia from Discovery to Benefit for all : Editorial to: "Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/Dl or Higher" by Henry N. Ginsberg et Al.
Academic Article Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial.
Academic Article Drug therapy in children and adolescents with familial hypercholesterolemia.
Academic Article Identification and management of heterozygous familial hypercholesterolemia: summary and recommendations from an NHLBI workshop.
Academic Article Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study.
Academic Article Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Academic Article PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial.
Academic Article Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia.
Academic Article Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group.
Academic Article Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study.
Academic Article Effect of the proprotein convertase subtilisin/kexin 9 monoclonal antibody, AMG 145, in homozygous familial hypercholesterolemia.
Academic Article Effect of a monoclonal antibody to PCSK9 on LDL cholesterol.
Academic Article Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia.
Academic Article Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study.
Academic Article Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Academic Article Treatment of familial hypercholesterolaemia in children and adolescents in the last three decades.
Academic Article Portacaval shunt in patients with familial hypercholesterolemia.
Academic Article Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial.
Academic Article Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.
Academic Article Rationale for early detection and treatment of hyperlipidemias.
Academic Article Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)".
Academic Article A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia.
Academic Article [The role of essential hyperlipemia & hypercholesteremia in the pathogenesis of myocardial infarcts; a contribution to the causal evaluation of cardiacs with infarcts].
Academic Article Usefulness of Gemcabene in Homozygous Familial Hypercholesterolemia (from COBALT-1).
Academic Article Long-Term Evolocumab in Patients With Familial Hypercholesterolemia.
Academic Article Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program.
Academic Article LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial.

Search Criteria
  • Hyperlipoproteinemia Type II